Anti-inflammatory therapies in atopic dermatitis (Q38812100)

6 September 2017

1 reference

title

Anti-inflammatory therapies in atopic dermatitis (English)

1 reference

6 September 2017

A Heratizadeh

1

1 reference

PubMed ID

27735066

6 September 2017

T Werfel

series ordinal

2

1 reference

6 September 2017

13 October 2016

1 reference

6 September 2017

1 reference

6 September 2017

71

1 reference

6 September 2017

12

1 reference

6 September 2017

1666-1675

1 reference

Global Allergy Forum and 3rd Davos Declaration 2015: Atopic dermatitis/Eczema: challenges and opportunities toward precision medicine

6 September 2017

1 reference

Meta-analysis identifies seven susceptibility loci involved in the atopic march

21 January 2018

1 reference

The adaptive immune system in atopic dermatitis and implications on therapy.

21 January 2018

1 reference

Atopic dermatitis and skin allergies - update and outlook

21 January 2018

1 reference

Cellular and molecular immunologic mechanisms in patients with atopic dermatitis

21 January 2018

1 reference

Atopic dermatitis from adolescence to adulthood in the TOACS cohort: prevalence, persistence and comorbidities.

21 January 2018

1 reference

Atopic dermatitis and the atopic march revisited

21 January 2018

1 reference

Systemic therapy for atopic dermatitis

21 January 2018

1 reference

Off-label prescriptions for atopic dermatitis in Europe

21 January 2018

1 reference

Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber.

21 January 2018

1 reference

α-NAC-Specific Autoreactive CD8+ T Cells in Atopic Dermatitis Are of an Effector Memory Type and Secrete IL-4 and IFN-γ.

21 January 2018

1 reference

Intrinsic properties of germinal center-derived B cells promote their enhanced class switching to IgE.

21 January 2018

1 reference

IL-33 impacts on the skin barrier by downregulating the expression of filaggrin.

21 January 2018

1 reference

Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD).

21 January 2018

1 reference

Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial

21 January 2018

1 reference

CD8(+) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-γ, IL-13, IL-17, and IL-22.

21 January 2018

1 reference

Atopic dermatitis phenotype with early onset and high serum IL-13 is linked to the new development of bronchial hyperresponsiveness in school children.

21 January 2018

1 reference

Mast cells and basophils in cutaneous immune responses

21 January 2018

1 reference

Possible Pathogenic Role of Th17 Cells for Atopic Dermatitis

21 January 2018

1 reference

The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization

21 January 2018

1 reference

Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.

21 January 2018

1 reference

Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis.

21 January 2018

1 reference

Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population

21 January 2018

1 reference

IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells

21 January 2018

1 reference

EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders

21 January 2018

1 reference

Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis

21 January 2018

1 reference

Staphylococcal exotoxins induce interleukin 22 in human th22 cells

21 January 2018

1 reference

IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis

21 January 2018

1 reference

Interleukin (IL)-31 activates signal transducer and activator of transcription (STAT)-1, STAT-5 and extracellular signal-regulated kinase 1/2 and down-regulates IL-12p40 production in activated human macrophages

21 January 2018

1 reference

IL-31: a new link between T cells and pruritus in atopic skin inflammation

21 January 2018

1 reference

IL-31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis.

21 January 2018

1 reference

Pathophysiology and therapy of pruritus in allergic and atopic diseases

21 January 2018

1 reference

IL-31 regulates differentiation and filaggrin expression in human organotypic skin models

21 January 2018

1 reference

The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, plac

21 January 2018

1 reference

Severe refractory atopic dermatitis in an adolescent patient successfully treated with ustekinumab

21 January 2018

1 reference

Inadequate response to ustekinumab in atopic dermatitis - a report of two patients.

21 January 2018

1 reference

Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis

21 January 2018

1 reference

Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signaling.

21 January 2018

1 reference

TSLP acts on infiltrating effector T cells to drive allergic skin inflammation

21 January 2018

1 reference

The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch

21 January 2018

1 reference

Cellular and molecular mechanisms of TSLP function in human allergic disorders--TSLP programs the "Th2 code" in dendritic cells.

21 January 2018

1 reference

Association of a new-type prostaglandin D2 receptor CRTH2 with circulating T helper 2 cells in patients with atopic dermatitis

21 January 2018

1 reference

Genetic variation in CRTh2 influences development of allergic phenotypes.

21 January 2018

1 reference

Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitis

21 January 2018

1 reference

Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis

21 January 2018

1 reference

Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment.

21 January 2018

1 reference

Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis

21 January 2018

1 reference

Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate

21 January 2018

1 reference

Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial.

21 January 2018

1 reference

Discovery and early clinical development of 2-{6-[2-(3,5-dichloro-4-pyridyl)acetyl]-2,3-dimethoxyphenoxy}-N-propylacetamide (LEO 29102), a soft-drug inhibitor of phosphodiesterase 4 for topical treatment of atopic dermatitis

21 January 2018

1 reference

Randomized comparison of the type 4 phosphodiesterase inhibitor cipamfylline cream, cream vehicle and hydrocortisone 17-butyrate cream for the treatment of atopic dermatitis

21 January 2018

1 reference

Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults.

21 January 2018

1 reference

Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: results of a randomized, vehicle-controlled, multicenter clinical trial.

21 January 2018

1 reference

A pilot study of an oral phosphodiesterase inhibitor (apremilast) for atopic dermatitis in adults

21 January 2018

1 reference

Apremilast Use for Moderate-to-Severe Atopic Dermatitis in Pediatric Patients

21 January 2018

1 reference

Diverse activation and differentiation of multiple B-cell subsets in patients with atopic dermatitis but not in patients with psoriasis.

21 January 2018

1 reference

ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients.

21 January 2018

1 reference

Increased efficacy of omalizumab in atopic dermatitis patients with wild-type filaggrin status and higher serum levels of phosphatidylcholines

21 January 2018

1 reference

IgE+ B cells are scarce, but allergen-specific B cells with a memory phenotype circulate in patients with allergic rhinitis.

21 January 2018

1 reference

Histamine suppresses epidermal keratinocyte differentiation and impairs skin barrier function in a human skin model

21 January 2018

1 reference

The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update

21 January 2018

1 reference

The histamine H4 receptor is functionally expressed on T(H)2 cells

21 January 2018

1 reference

Human memory Th17 cells express a functional histamine H4 receptor.

21 January 2018

1 reference

The histamine H4 receptor: from orphan to the clinic

21 January 2018

1 reference

Histamine H4 receptor knockout mice display reduced inflammation in a chronic model of atopic dermatitis.

21 January 2018

1 reference

Induction of atopic dermatitis by inhalation of house dust mite

21 January 2018

1 reference

The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study.

21 January 2018

1 reference

Atopic dermatitis: new evidence on the role of allergic inflammation

21 January 2018

1 reference

Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis.

21 January 2018

1 reference

Specific allergen immunotherapy for the treatment of atopic eczema: a Cochrane systematic review

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ALL.13065

1 reference

6 September 2017

1 reference

PubMed ID

27735066